logo
1-800-590-1161ContactEarn free travel
logo1-800-590-1161

Entry Requirements

Enter the name of the tour you’re reserved on, or have on your wish list, to view the most up to date entry requirements.

Choose a different tour

Tanzania Wildlife Safari

Choose departure year
    EF Go Ahead Tours currently requires that all tour participants be fully vaccinated against COVID-19 and must have proof of negative results for a COVID-19 test
    taken within 72-hours before departure. These requirements are in addition to any destination requirements listed below due to US Department of State and CDC guidance, the wellbeing of the group, and/or operational feasibility.

    The United States to Tanzania, United Republic of

    Please note: Local requirements may be listed for destinations not visited on your tour itinerary. Cross-reference your itinerary to confirm which guidelines apply to you.

    General information

    Health screening on arrival NEEDED ON ARRIVAL

    Temperature and health screening are required for all travelers on arrival in Tanzania.

    US Embassy for Tanzania
    Mandatory COVID-19 test on arrival NEEDED ON ARRIVAL

    Travelers arriving from or have traveled through selected countries in the last 14 days must take a COVID-19 rapid test on arrival at their own expense. Please see the source for more details.

    This requirement does not apply to: -Travelers in transit; -Travelers aged 5 years and under.

    Documents needed

    Mandatory health surveillance form for ZanzibarNEEDED BEFORE ARRIVAL

    Travelers are required to complete an online Health Surveillance Form a maximum of 24 hours before arrival in Zanzibar. Travelers will then receive a Unique Health Code (UHC), which they will present to health officials upon arrival.

    Proof of negative pre-departure COVID-19 test resultsNEEDED BEFORE ARRIVAL

    Travelers must have a negative COVID-19 RT-PCR or NAAT test result. The test must be taken a maximum of 96 hours before departure to Tanzania.

    This requirement does not apply to: -Travelers in transit; -Travelers aged 5 years and under.

    Electronic visitor visaNEEDED BEFORE ARRIVAL

    To visit Tanzania for Business or Tourism, you require a visa. An eVisa is the fastest and easiest way of obtaining a visa as you can submit an application and supporting documents online. If approved, you'll receive your eVisa confirmation electronically. When you arrive at immigration, you will be asked for your passport and eVisa to ensure you have proper documentation.

    Mandatory health surveillance form for Tanzania MainlandNEEDED BEFORE ARRIVAL

    Travelers are required to complete an online Health Surveillance Form a maximum of 24 hours before arrival in Tanzania. Travelers will then receive a Unique Health Code (UHC), which they will present to health officials upon arrival.

    Tanzania, United Republic of to The United States

    Please note: Local requirements may be listed for destinations not visited on your tour itinerary. Cross-reference your itinerary to confirm which guidelines apply to you.

    General information

    Masks are mandatory on public transportation

    Travelers must wear masks on public transportation in the United States. Some states still require the use of masks in public places, please verify the regional requirements before traveling.

    Documents needed

    Mandatory travel attestation formNEEDED BEFORE ARRIVAL

    Travelers must complete a travel attestation form before arrival. This form will be provided by the airline. Airlines may let you complete your attestation electronically, such as through the VeriFLY app. However, you may still want to keep a printed copy as a precaution. Section 1 of the form below must be completed by all travelers while section 2 must only be completed by travelers that are not citizens or residents of the USA.

    Proof of negative pre-departure COVID-19 test resultsNEEDED BEFORE ARRIVAL

    All travelers regardless of their vaccination status must have an original printed or electronic negative COVID-19 viral test result (NAAT: RT-PCR, RT-LAMP, TMA, NEAR, HDA, or Antigen: Rapid). The test must be taken 1 day before the first scheduled departure time in the flight itinerary. Test results must include the traveler's full name and at least one other identifier such as date of birth or passport number. The test must also clearly state that the results are "negative," SARS-CoV-2 RNA not detected," SARS-CoV-2 antigen not detected," or "COVID-19 not detected." A test marked "invalid" is not acceptable. This requirement applies to all travelers, including US citizens, residents, and transit travelers. Travelers may use a self-test (sometimes referred to as a home test) that meets the given criteria. Please check the source for more information. Some US states might have more strict rules regarding COVID-19 test types and where they must be administered. Please carefully review the rules before traveling to each state.

    This requirement does not apply to: -Travelers under the age of 2; -Travelers who have recovered from COVID-19. These travelers must show proof of a positive viral test from the preceding 90 days and a letter from their healthcare provider or public health official stating they are cleared to end isolation. Please see the source for more details.

    Mandatory proof of vaccinationNEEDED BEFORE ARRIVAL

    Travelers are considered fully vaccinated against COVID-19 if 2 weeks have passed since their second dose in a 2-dose series, such as the Pfizer-BioNTech or Moderna vaccines, or 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine. The US government currently accepts vaccines approved or authorized for emergency use by the U.S. FDA and the WHO. Vaccines accepted are Pfizer-BioNTech (e.g., COMIRNATY, Tozinameran), AstraZeneca-Oxford (e.g., Covishield, Vaxzevria), Janssen (Johnson & Johnson), Moderna, Sinopharm BIBP, Covaxin and Sinovac-CoronaVac. Travelers unable to present a valid certificate may be required to comply with rules for unvaccinated travelers.

    Any combination of 2 doses of an FDA approved/authorized or WHO emergency use listed COVID-19 2-dose series are accepted. The second dose in a 2-dose heterologous series must have been received no earlier than 17 days (21 days with a 4 day grace period) after the first dose. For more information about accepted proof of vaccination, please check the source.